Therefore, the decline in PSA with increase in serum selenium among men carrying the GPX1 rs1050450 T allele in our study is an indirect reflection of prostate health benefits that may parallel prostate cancer risk reduction as recorded by the Steinbrecher et al. study [68]. This evidence concerns the gene GPX1 and Familial prostate cancer.